Metabolon, Inc.

Global leader in metabolomics for drug development, biomarker discovery, and advancing microbiome, pharma & life sciences research.

[Metabolon, Inc. @Metabolon]

Can multiomics help define phenotypes, better understand disease, & identify new biomarkers?

In our recent webinar, Vivek Das explains how @novonordisk applied multiomics to reveal molecular signatures linked to plaque instability in atherosclerosis.

https://t.co/B3pppxoiCp

[Metabolon, Inc. @Metabolon]

At #ASMS2026?

Join us tomorrow at 7:00 AM in Room 33C for the Metabolon Breakfast Seminar and an early look at Metabolon Verus™, our new metabolomics profiling kit.

Can't attend in person? Watch it live! https://t.co/xOJCX8ZeiU

[Metabolon, Inc. @Metabolon]

We’re excited for #ASMS2026 in San Diego!

Visit Metabolon at Booth #820 to learn about Metabolon Verus™, our new metabolomics kit for scalable, reproducible workflows.

Join our breakfast session and poster presentation on June 3.

And don't miss the great giveaways! 🎁

[Metabolon, Inc. @Metabolon]

Today is an exciting milestone: the launch of our first kit — the Metabolon Verus™ Metabolomics Profiling Kit.

Built on 25+ years of expertise, Metabolon Verus™ brings reproducible metabolomics into labs worldwide.

Learn more at #ASMS2026 and here: https://t.co/UZFbPknQc7

[Metabolon, Inc. @Metabolon]

Join our webinar with Dr. Olivia Gray (@VariantBio) tomorrow!

Learn how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.

📅 27 May
🕒 11 am EDT | 5 pm CEST

🔗https://t.co/mQVsUg0tOS

[Metabolon, Inc. @Metabolon]

Can genetics bias kidney disease biomarkers?

In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.

📅 27 May
🕑 11 am EDT | 5 pm CEST

🔗 https://t.co/mQVsUg0tOS

[Metabolon, Inc. @Metabolon]

Heading to #GBA1Meeting2026 in Phoenix?

Greg Michelotti from Metabolon will be there discussing our work in GBA1 research, including our collaboration with The Michael J. Fox Foundation. Connect with him during the meeting to learn more.

[Metabolon, Inc. @Metabolon]

New research in Nature Communications used Metabolon’s Complex Lipid Panel to uncover novel genetic links to lipid metabolism and disease pathways, highlighting the power of species-level lipidomics at population scale.

Read the full paper here: https://t.co/oUa9TS02zh

[Metabolon, Inc. @Metabolon]

Can genetics bias kidney disease biomarkers?

In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.

📅 27 May
🕑 11 am EDT | 5 pm CEST

🔗 https://t.co/mQVsUg0tOS

[Metabolon, Inc. @Metabolon]

Don't forget our next webinar with Vivek Das, PhD, from Novo Nordisk.

Learn how integrated multiomics + metabolomics revealed signatures linked to plaque instability in atherosclerosis.

📅 May 19
🕑 10 am EDT | 4 pm CEST
Register: https://t.co/36aG0WqYl7

[Metabolon, Inc. @Metabolon]

Multiomics is reshaping biomarker discovery.

Join our upcoming webinar with Dr. Vivek Das (Novo Nordisk), who will share how multiomics revealed signatures of plaque instability, and why metabolomics was key.

📅 May 19 | 🕑 10am EDT / 4pm CEST
Register: https://t.co/36aG0Wqqvz

[Metabolon, Inc. @Metabolon]

Innovation starts with people.

In her latest blog, Metabolon VP of HR Celia Reyes shares how culture, leadership, and employee growth help drive long-term impact and success at Metabolon.

Read more: https://t.co/DlzzgRtnl2

[Metabolon, Inc. @Metabolon]

At Metabolon, connection goes beyond the lab. Recently, employees gathered for a game of Warhammer 40K, bringing strategy, creativity, and friendly competition to the tabletop.

Here’s to the shared passions that make our culture uniquely Metabolon.

[Metabolon, Inc. @Metabolon]

We’re excited to be at #ARVO2026 this week!

Stop by Booth #6047 to meet the team and learn how metabolomics can help advance our understanding of retinal disease and support biomarker discovery.

[Metabolon, Inc. @Metabolon]

Multiomics is reshaping biomarker discovery.

Join our upcoming webinar with Dr. Vivek Das (Novo Nordisk), who will share how multiomics revealed signatures of plaque instability, and why metabolomics was key.

📅 May 19 | 🕑 10am EDT / 4pm CEST
Register: https://t.co/36aG0Wqqvz

[Metabolon, Inc. @Metabolon]

During #LabProfessionalsAppreciationWeek, we’re proud to recognize our Laboratory Operations team.

Their expertise, precision, and collaboration turn complex science into trusted results and real impact.

Thank you for everything you do, your work drives our progress every day.

[Metabolon, Inc. @Metabolon]

Proud to see colleagues Dr. Adam Kennedy & Dr. Greg Michelotti leading a new Metabolites Special Issue: https://t.co/sPifZ0iekW

“Advances in Metabolomics for Precision Medicine” explores earlier disease detection, new biomarkers, and improved tracking of therapeutic response.

[Metabolon, Inc. @Metabolon]

Reliability is often overlooked in #metabolomics, but it shouldn’t be.

At Metabolon, a systems-level approach to QC, harmonization, and maintenance reduces rework to ~3% and protects uptime.

Operational excellence = better data, better outcomes.

Read: https://t.co/wItsCfdnmz

[Metabolon, Inc. @Metabolon]

What turns insight into impact?

Michael Irwin, our VP of Sales, shares why belief + disciplined execution drive real results.

At Metabolon, that’s how we’re advancing metabolomics in the multiomics landscape.

Read more: https://t.co/ojdpqB4F12

[Metabolon, Inc. @Metabolon]

Live from #ADPD2026

Advancing Parkinson’s research by capturing real-time biochemical changes, in collaboration with @MichaelJFoxOrg.

Come by booth #01C to learn more!

[Metabolon, Inc. @Metabolon]

We are thrilled to join the #EPILifestyle26 conference in Boston this week and discuss how to leverage metabolomic analysis to dissect cardiometabolic risk in large-scale population studies.

Meet Tony di Meco and Katherine Black at booth #6 between March 17th and 20th!

[Metabolon, Inc. @Metabolon]

At #ADPD2026? Come by booth #01C to learn how metabolomics can support your neuroscience research.

[Metabolon, Inc. @Metabolon]

We’re proud to announce our collaboration with The Michael J. Fox Foundation to advance multiomic analyses and biomarker discovery in Parkinson’s research, a disease where diagnosis and treatment remain challenging despite its prevalence.

🔗https://t.co/7yhjuXyiOI